TY - JOUR
T1 - Human embryonic stem cells carrying mutations for severe genetic disorders
AU - Frumkin, Tsvia
AU - Malcov, Mira
AU - Telias, Michael
AU - Gold, Veronica
AU - Schwartz, Tamar
AU - Azem, Foad
AU - Amit, Ami
AU - Yaron, Yuval
AU - Ben-Yosef, Dalit
N1 - Funding Information:
Acknowledgments The authors thank the embryologists Ariela Carmon, Tanya Cohen, and Nava Mei-Raz for their skillful assistance; this research was partly funded by a grant from the Fragile X Foundation and by Israel Science Foundation grant #227/06. Esther Eshkol is thanked for editorial assistance and Sigalit Siso for the graphics.
PY - 2010/4
Y1 - 2010/4
N2 - Human embryonic stem cells (HESCs) carrying specific mutations potentially provide a valuable tool for studying genetic disorders in humans. One preferable approach for obtaining these cell lines is by deriving them from affected preimplantation genetically diagnosed embryos. These unique cells are especially important for modeling human genetic disorders for which there are no adequate research models. They can be further used to gain new insights into developmentally regulated events that occur during human embryo development and that are responsible for the manifestation of genetically inherited disorders. They also have great value for the exploration of new therapeutic protocols, including gene-therapy-based treatments and disease-oriented drug screening and discovery. Here, we report the establishment of 15 different mutant human embryonic stem cell lines derived from genetically affected embryos, all donated by couples undergoing preimplantation genetic diagnosis in our in vitro fertilization unit. For further information regarding access to HESC lines from our repository, for research purposes, please email [email protected].
AB - Human embryonic stem cells (HESCs) carrying specific mutations potentially provide a valuable tool for studying genetic disorders in humans. One preferable approach for obtaining these cell lines is by deriving them from affected preimplantation genetically diagnosed embryos. These unique cells are especially important for modeling human genetic disorders for which there are no adequate research models. They can be further used to gain new insights into developmentally regulated events that occur during human embryo development and that are responsible for the manifestation of genetically inherited disorders. They also have great value for the exploration of new therapeutic protocols, including gene-therapy-based treatments and disease-oriented drug screening and discovery. Here, we report the establishment of 15 different mutant human embryonic stem cell lines derived from genetically affected embryos, all donated by couples undergoing preimplantation genetic diagnosis in our in vitro fertilization unit. For further information regarding access to HESC lines from our repository, for research purposes, please email [email protected].
KW - Human embryonic stem cells
KW - Preimplantation genetic diagnosis (PGD)
UR - http://www.scopus.com/inward/record.url?scp=77952094754&partnerID=8YFLogxK
U2 - 10.1007/s11626-010-9275-5
DO - 10.1007/s11626-010-9275-5
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 20186514
AN - SCOPUS:77952094754
SN - 1071-2690
VL - 46
SP - 327
EP - 336
JO - In Vitro Cellular and Developmental Biology - Animal
JF - In Vitro Cellular and Developmental Biology - Animal
IS - 3-4
ER -